Event Details
AcelRx Pharmaceuticals, Inc. to Discuss Phase 3 Top-line Results Involving the Sufentanil NanoTab PCA System - Conference Call
Nov 15, 2012 from at 8:00 AM to 8:00 AM EST
Live Teleconference Information
Primary # -
Secondary # -
